A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
Clinical trial NCT05425056 · COMPLETED
Trial details
- NCT number
- NCT05425056
- Sponsor
- Vascular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2025-03-18
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.